Tag: Sanofi

ABL Bio, Sanofi sign $1bn deal for Parkinson’s candidate ABL301

businessnewstoday- January 14, 2022 0

ABL Bio has bagged a global collaboration and licensing deal worth up to $1.06 billion with Sanofi to develop and commercialize its drug candidate ABL301 ... Read More

Sanofi to acquire UK-based biopharma company Kymab in $1.4bn worth deal

pharmanewsdaily- January 12, 2021 0

Sanofi acquisition of Kymab : French pharma giant Sanofi has signed a deal worth up to $1.45 billion to acquire Kymab, a UK-based clinical-stage biopharma ... Read More

Sanofi to acquire US biopharma company Principia Biopharma for $3.7bn

pharmanewsdaily- August 17, 2020 0

Sanofi acquisition of Principia Biopharma : French pharma giant Sanofi has signed an all-cash deal worth $3.68 billion to acquire Principia Biopharma, a late-stage California-based ... Read More

Perrigo acquires skincare and hair loss treatment brands from Sanofi

businessnewstoday- August 11, 2020 0

Ireland-based Perrigo Company has agreed to acquire three over-the-counter (OTC) skincare and hair loss treatment brands sold across Eastern Europe, namely Emolium, Iwostin, and Loxon, ... Read More

Sanofi, GSK to supply 60 million doses of COVID-19 vaccine to UK

pharmanewsdaily- July 30, 2020 0

Pharma majors Sanofi and GlaxoSmithKline (GSK) have reached an agreement with the UK government for supplying up to 60 million doses of their jointly developed ... Read More

Mylan, Biocon get FDA approval for Semglee in type 1 and 2 diabetes

pharmanewsdaily- June 12, 2020 0

Mylan and Biocon have secured approval from the US Food and Drug Administration (FDA) for Semglee (insulin glargine injection) in vial and pre-filled pen presentations ... Read More

Dupixent delivers positive results in eosinophilic esophagitis trial

pharmanewsdaily- May 24, 2020 0

Regeneron Pharmaceuticals and Sanofi said that their co-developed eczema drug Dupixent (dupilumab) has met the co-primary endpoints of Part A of a phase 3 trial ... Read More

Vaccine giants Sanofi, GSK announce COVID-19 vaccine partnership

pharmanewsdaily- April 17, 2020 0

French pharma company Sanofi has announced a COVID-19 vaccine partnership with GlaxoSmithKline (GSK) to develop an adjuvanted vaccine for the novel coranavirus, by combining their ... Read More

Baxter to acquire Seprafilm Adhesion Barrier from Sanofi for $350m

pharmanewsdaily- January 2, 2020 0

Baxter International, a US-based health care company, has signed a deal worth $350 million to acquire Seprafilm Adhesion Barrier and related assets from French pharma ... Read More

Sanofi, Regeneron secure Libtayo EMA approval for a type of skin cancer

pharmanewsdaily- July 21, 2019 0

Libtayo EMA approval : The European Commission has given conditional approval for Libtayo (cemiplimab) for the treatment of adult patients with metastatic or locally advanced ... Read More